KEARY HINDS: Open Payments
NPI 1467157925 · WEST MILFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 14 payments from 5 companies in 2025. Trend: 2023 $81 · 2024 $279 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $413 |
| Gilead Sciences, Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $24 |
Products named: REPATHA, KRYSTEXXA, GVOKE HYPOPEN, AIRSUPRA, Ozempic, BREZTRI.
Industry payments across NJ — which companies pay providers there.
